MapLight Therapeutics, Inc. (MPLT)
7.25
+0.18
(+2.55%)
USD |
NASDAQ |
Nov 13, 16:00
7.25
0.00 (0.00%)
After-Hours: 19:59
MapLight Therapeutics Shareholders Equity (Quarterly) : 348.30M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 348.30M |
| March 31, 2026 | 399.83M |
| December 31, 2025 | 458.37M |
| September 30, 2025 | 233.52M |
| Date | Value |
|---|---|
| June 30, 2025 | 63.76M |
| March 31, 2025 | 93.00M |
| June 30, 2024 | |
| March 31, 2024 | 172.83M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -7.503M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.529B |
| Anixa Biosciences, Inc. | 14.47M |
| Vicapsys Life Sciences, Inc. | -3.549M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 368.35M |
| Total Liabilities (Quarterly) | 20.05M |
| Debt to Equity Ratio | 0.0057 |
| Current Ratio | 16.52 |
| Net Debt Paydown Yield | 0.05% |